Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis

Journal of Cell Science

Volumn 113, Issue 17, 2000, Pages 2941-2953

  Johnson, V L ^a   Ko, S C W ^a   Holmstrom, T H ^a   Eriksson, J E ^a   Chow, S C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Apoptosis; Caspase; Morphology

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE 2; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE INHIBITOR; CHEMICAL AGENT; CYTOCHROME C; DNA; ETOPOSIDE; KETONE DERIVATIVE; N ACETYLTYROSINE; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLSERINE; STAUROSPORINE;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL DEATH; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL STRAIN MCF 7; CHROMATIN CONDENSATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; EFFECTOR CELL; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LEUKEMIA CELL LINE; MITOCHONDRION; MOLECULAR WEIGHT; MORPHOLOGY; PRIORITY JOURNAL;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASES; CELL LINE; CELL NUCLEUS; CHELATING AGENTS; CHROMATIN; CYSTEINE PROTEINASE INHIBITORS; ENDOPLASMIC RETICULUM; ENZYME INHIBITORS; ETHYLENEDIAMINES; ETOPOSIDE; HUMAN; JURKAT CELLS; MUTATION; NUCLEAR ENVELOPE; NUCLEIC ACID SYNTHESIS INHIBITORS; OLIGOPEPTIDES; POLY(ADP-RIBOSE) POLYMERASES; STAUROSPORINE; SUPPORT, NON-U.S. GOV'T;

EID: 0033828987     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Human ICE/CED-3 protease nomenclature
2. Apoptosis: Mechanisms and roles in pathology
3. Cytotoxic T lymphocyte-assisted suicide: Caspase 3 activation is primarily the result of the direct action of granzyme B
4. Involvement of MACH, a novel MORT/FADD-interacting protease in Fas/APO-1 and TNF-receptor-induced cell death
5. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization
6. Caspase-1 is not involved in Fas-mediated apoptosis in Jurkat T cells
7. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation
8. Caspases: The executioners of apoptosis
9. Genetic control of programmed cell death in the nematode C elegans
10. Mechanisms and functions of cell death
11. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
12. Identification of a cysteine protease closely related to interleukin-1beta-converting enzyme
13. Inhibition of caspases by peptide-based and macromolecular inhibitors
14. Apoptotic pathways: The roads to ruin
15. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro
16. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
17. Caspase-3 is required for a-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis
18. 2+
19. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspase
20. Chromatin condensation during apoptosis requires ATP
21. The ICE family of cysteine proteases as effectors of cell death
22. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE
23. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
24. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
25. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
26. Flice, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex
27. An induced proximity model for caspase-8 activation
28. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
29. Caspases: Killer proteases
30. Nuclear pore clustering is a consistent feature of apoptosis in vitro
31. Caspases: Intracellular signaling by proteolysis
32. Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic execution
33. Benzyloxycarbonyl-val-ala-asp (OMe) fluoromethylketone (z-VAD. fmk) inhibits apoptosis by blocking the processing of CPP32
34. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases
35. Pro-caspase-3 is a major physiologic target of caspase-8
36. Molecular characterization of mitochondrial apoptosis-inducing factor
37. Substrate specificities of caspase family proteases
38. Apotosis and the pathogenesis and treatment of disease
39. A combinatorial approach defines specificities of members of the caspase family and granzyme B: Functional relationships established for key mediators of apoptosis
40. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure
41. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes
42. Endonuclease activities associated with high molecular weight and internucleosomal DNA fragmentation in apoptosis
43. Cellular events in Fas/APO-1-mediated apoptosis in JURKAT T lymphocytes
44. The temporal relationship between protein phosphatase, mitochondrial cytochrome c release, and caspase activation in apoptosis
45. The genetic regulation of apoptosis
46. Essential role of CED-4 oligomerization in CED-3 activation and apoptosis
47. The C. Elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1b-converting enzyme
48. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3